End-to-End Clinical Trial & CRO Services in Singapore
Driving Life Sciences Innovation Through Strategic GxP Compliance and Regulatory Excellence
Singapore represents a major global center for pharmaceutical innovation and healthcare, supported by top-tier infrastructure and a skilled workforce. Its life sciences sectors are regulated by the Health Sciences Authority (HSA), which ensures compliance with international standards like ICH guidelines and Good Clinical Practice (GCP), facilitating efficient development and commercialization in the industry.
Singapore serves as a strategic gateway to Asian and global markets, promoting research excellence and technological innovation. Organizations must ensure quality systems and regulatory compliance. Zenovel offers GxP compliance, quality assurance, regulatory affairs, clinical research, and consulting services to help pharmaceutical and healthcare organizations navigate regulatory landscapes and enhance operational performance for sustainable growth.
Good Clinical Practice (GCP) Services in Singapore for Clinical Research Excellence
Enhancing Clinical Trial Quality Through Strategic GCP Compliance
Singapore excels as a premier clinical research hub in the Asia-Pacific, backed by robust healthcare infrastructure and esteemed research institutions. Clinical trials are governed by the Health Sciences Authority (HSA) and adhere to ICH-GCP guidelines, ensuring participant safety and research integrity. Zenovel offers extensive Good Clinical Practice (GCP) services to assist pharmaceutical, biotechnology, medical device, and healthcare organizations in compliance and optimizing clinical trial operations.
Our GCP Services in Singapore Include:
- Clinical Quality and GCP Consulting: Improve clinical quality frameworks, governance structures, and compliance programs to improve trial performance.
- Regulatory and GCP Compliance Support: Guidance on HSA regulations, ICH-GCP requirements, ethics committee expectations, and applicable international clinical research standards.
- Inspection Readiness and Quality Management: Preparation for regulatory inspections through gap assessments, mock audits, documentation reviews, quality evaluations, and CAPA planning.
- Sponsor Oversight and Vendor Governance: Establishment of effective oversight models for CROs, service providers, and clinical sites to ensure accountability and compliance.
- Risk-Based Quality Management: Implementation of risk-based monitoring, quality management systems, and proactive risk mitigation strategies to safeguard participant safety and data reliability.
- Clinical Compliance Assessments: Independent reviews of clinical trial processes, documentation, and operational practices to identify improvement opportunities and strengthen regulatory readiness.
Zenovel supports organizations in Singapore by providing practical, risk-based GCP solutions that uphold high standards of clinical research. Our expertise ensures regulatory compliance, operational excellence, quality oversight, and readiness for inspections, facilitating successful clinical development programs in line with both local and international standards.
Computer System Validation (CSV) Services in Singapore for GxP Compliance and Data Integrity
Ensuring Reliable, Compliant, and Inspection-Ready Computerized Systems
As Singapore enhances its status as a hub for life sciences and healthcare innovation, the demand for validated computerized systems is growing. These systems are crucial for clinical research and regulatory compliance. Zenovel offers comprehensive Computer System Validation (CSV) Services, adhering to GAMP 5 principles and regulatory requirements like ICH-GCP and 21 CFR Part 11, to ensure data integrity and patient safety across various organizations in the sector.
Our CSV Services in Singapore Include:
- Validation Planning and Strategy Development: Validation plans, system validation strategies, and compliance frameworks tailored to organizational and regulatory requirements.
- Requirements and Traceability Management: Review and management of user requirements, functional specifications, design documentation, and traceability matrices.
- Risk Assessment and System Classification: Evaluation of system criticality, compliance risks, and validation requirements to support a risk-based validation approach.
- IQ/OQ/PQ Execution and Support: Planning, execution, and documentation of Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) activities.
- Data Integrity and Security Assessments: Review of audit trails, user access controls, electronic records, data governance practices, and system security controls.
- Electronic Records and Electronic Signature Compliance: Support for compliance with applicable electronic record and e-signature requirements, including EU Annex 11 and 21 CFR Part 11 expectations.
- Change Control and System Lifecycle Management: Support for system upgrades, modifications, periodic reviews, retirement activities, and ongoing compliance management.
- Validation Documentation and Quality Support: Preparation and review of validation protocols, reports, SOPs, test scripts, and supporting validation documentation.
Zenovel provides services to ensure compliance with HSA expectations, GAMP 5 guidance, ICH-GCP principles, GxP regulations, EU Annex 11, and data integrity standards. We assist organizations in creating and maintaining validated computerized environments, emphasizing regulatory compliance, operational efficiency, and robust data management through a risk-based approach to minimize compliance risks and enhance data integrity.
GCP Audit Services in Singapore for Clinical Research Quality and Compliance
Improving Clinical Trial Excellence Through Independent GCP Audits
Effective quality oversight is crucial for participant safety, data reliability, and regulatory compliance in clinical trials. Zenovel offers independent GCP Audit Services in Singapore to help sponsors, CROs, investigator sites, and service providers enhance quality systems and adhere to clinical research regulations. Our audits, conducted with a risk-based approach, align with HSA requirements, ICH E6(R3) GCP guidelines, and international standards.
Our GCP Audit Services in Singapore Include:
- Clinical Site Audits: Evaluation of site operations, protocol compliance, informed consent processes, participant safety measures, source documentation, and essential records.
- Sponsor and CRO Audits: Evaluation of governance frameworks, quality management systems, oversight activities, operational processes, and regulatory compliance programs.
- Vendor and Service Provider Audits: Review of laboratories, technology vendors, data management providers, and other third-party partners supporting clinical research activities.
- Quality Management System Reviews: Assessment of SOPs, training programs, deviation handling, CAPA systems, quality metrics, and compliance processes.
- Regulatory Compliance Assessments: Evaluation of adherence to HSA requirements, ICH-GCP guidelines, and applicable international clinical research regulations.
- Data Integrity and Critical Process Audits: Review of data management practices, trial documentation, protocol adherence, record traceability, and participant protection processes.
- CAPA and Inspection Readiness Support: Support for corrective and preventive action planning, remediation activities, and preparation for regulatory inspections and sponsor audits.
Zenovel’s audit experts offer objective evaluations and actionable recommendations to enhance quality systems, bolster compliance, reduce risks, and ensure readiness for inspections, fostering continuous improvement in clinical research.
CRO Setup & Upgradation Services in Singapore for GCP and Regulatory Compliance
Building High-Performance CRO Operations for Sustainable Clinical Research Success
Singapore is a top clinical research hub in Asia, noted for its healthcare infrastructure and regulatory environment. To establish or improve a CRO, robust quality systems and adherence to regulatory standards are essential. Zenovel offers CRO Setup & Upgradation Services to help organizations develop compliant, scalable, and inspection-ready operations in line with HSA requirements and global clinical research standards.
New CRO Setup Services in Singapore
Our end-to-end CRO establishment solutions include:
- Clinical Operations Framework Development
- Organizational Structure and Governance Design
- Quality Management System (QMS) Implementation
- SOP Development and Documentation Management Systems
- Clinical Technology and Electronic System Implementation
- Risk-Based Monitoring Framework Development
- Vendor Qualification and Oversight Programs
- Clinical Quality and Compliance Frameworks
- Data Integrity and Regulatory Compliance Systems
- Workforce Training and GCP Capability Development
Existing CRO Upgradation Services in Singapore
For CROs seeking operational excellence and enhanced compliance, we offer:
- GCP Gap Assessments and Remediation Planning
- Quality System Enhancement and Modernization
- Sponsor Oversight Framework Strengthening
- Risk-Based Quality Management Implementation
- Clinical Monitoring Process Optimization
- Vendor Management and Governance Improvements
- CAPA System Evaluation and Enhancement
- Inspection Readiness and Compliance Programs
- Data Integrity and Computerized System Compliance Reviews
- Regulatory Alignment and Operational Excellence Initiatives
Zenovel assists CROs in governance enhancement, quality oversight, operational optimization, and regulatory compliance, enabling organizations to be inspection-ready and fostering client confidence for sustainable growth in Singapore’s dynamic clinical research environment.
PK-Stat Review Services in Singapore for Reliable Clinical Data Evaluation
Delivering Accurate Pharmacokinetic and Statistical Review for Regulatory Success
Zenovel offers pharmacokinetic (PK) and statistical review services in Singapore, helping pharmaceutical, biotechnology, and healthcare organizations ensure high-quality clinical evidence and regulatory compliance during clinical development.
Our PK-Stat Review Services in Singapore Include:
- PK/PD Analysis—Non-compartmental analysis (NCA), population PK modeling, exposure-response evaluation, and dose optimization.
- Regulatory Compliance Review – Alignment with Health Sciences Authority (HSA) requirements, ICH guidelines, and international regulatory expectations.
- Statistical Review & Data Validation – Clinical biostatistics review, data quality assessment, statistical verification, and submission-ready outputs.
- Regulatory Submission Support – Independent review for clinical trials, bioequivalence studies, marketing applications, and lifecycle submissions.
Zenovel enhances the quality, reliability, and regulatory acceptance of clinical data via expert pharmacokinetic and statistical reviews, aiding informed development decisions and successful submissions.
Pre-Inspection Readiness Services in Singapore for GCP Compliance
Strengthening Inspection Readiness Through Proactive Quality and Compliance Assessment
Regulatory inspections are essential for assessing the quality of clinical trials and ensuring participant safety and compliance with regulations. Zenovel offers Pre-Inspection Readiness Services in Singapore, assisting sponsors, CROs, and research organizations in preparing for these inspections, identifying compliance gaps, and enhancing quality systems. Our structured, risk-based approach focuses on clinical processes, documentation, oversight activities, and quality management systems to ensure readiness for evaluations by the HSA and other international agencies.
Our Pre-Inspection Readiness Services in Singapore Include:
- Mock Inspections and Readiness Assessments: Regulatory inspections, Organizational preparedness, identifying vulnerabilities, and Timely remediation.
- Clinical Trial Documentation Reviews: Assessment of Trial Master Files (TMF), informed consent documentation, safety reporting records, protocol compliance, essential documents, and data management practices.
- Quality System and Compliance Evaluations: Review of quality management systems, SOPs, vendor oversight processes, risk management frameworks, and compliance controls to enhance inspection readiness.
- CAPA Assessment and Remediation Support: Evaluation of CAPA programs, root cause investigations, implementation effectiveness, and long-term compliance sustainability.
- Sponsor Oversight and Vendor Governance Reviews: Assessment of CRO oversight models, vendor qualification procedures, governance structures, performance monitoring activities, and risk-based oversight processes.
- Inspection Readiness Training: Training of the clinical team covering inspection management, regulatory interactions, documentation retrieval, interview preparation, and inspection best practices.
Zenovel provides services that align with HSA requirements and ICH E6(R3) Good Clinical Practice guidelines. The organization aids Singaporean companies in enhancing compliance frameworks, operational quality, and regulatory inspection readiness through readiness assessments and remediation strategies, promoting sustainable compliance and effective clinical development.
Risk-Based Monitoring (RBM) Services in Singapore for Efficient Clinical Trials
Optimizing Clinical Trial Oversight Through Risk-Based Monitoring
Risk-Based Monitoring (RBM) improves clinical trial quality by targeting monitoring efforts on significant risks affecting participant safety and data integrity. Zenovel offers Risk-Based Monitoring Services in Singapore to assist sponsors and CROs in enhancing trial oversight through proactive, data-driven strategies.
Our RBM Services in Singapore Include:
- Risk Identification & Assessment – Early identification and evaluation of study risks.
- Centralized & Remote Monitoring – Continuous review of clinical and operational data.
- Risk-Based Monitoring Plans – Development of monitoring strategies aligned with ICH E6(R3).
- Data Quality & Site Performance Review – Monitoring protocol compliance, recruitment, data quality, and operational performance.
Zenovel integrates risk-based quality management into clinical operations to improve study efficiency, strengthen compliance, and support inspection-ready clinical trials aligned with HSA requirements and international GCP standards.
Sponsor Oversight Services in Singapore for Clinical Trial Governance and Compliance
Enhancing Clinical Trial Oversight Through Effective Governance
Strong sponsor oversight is crucial for participant safety, data integrity, and regulatory compliance in clinical development. Zenovel offers Sponsor Oversight Services in Singapore, enabling sponsors to effectively manage CROs, vendors, and clinical sites while ensuring compliance with HSA requirements, ICH E6(R3), and international Good Clinical Practice (GCP) standards.
Our Sponsor Oversight Services in Singapore Include:
- CRO & Vendor Oversight – Performance evaluation, qualification, compliance monitoring, and governance reviews.
- Clinical Governance Frameworks – Development of risk-based oversight models and sponsor governance strategies.
- Site Performance Monitoring – Review of recruitment, protocol compliance, data quality, and operational performance.
- Quality & Compliance Oversight – Monitoring of quality metrics, CAPA effectiveness, audit findings, and inspection readiness.
- Risk Assessment & Mitigation – Identification and management of operational, quality, and regulatory risks.
- Regulatory Compliance Support – Alignment with HSA requirements, ICH E6(R3), and international GCP expectations.
Zenovel supports sponsors with practical oversight solutions that strengthen governance, improve trial quality, reduce compliance risks, and ensure successful clinical trial execution across Singapore and global research programs.
Good Manufacturing Practice (GMP) Services in Singapore for Pharmaceutical Compliance
Supporting Manufacturing Excellence Through GMP Compliance
Maintaining GMP compliance is essential for product quality, patient safety, and regulatory confidence. Zenovel offers GMP Services in Singapore to assist pharmaceutical, biotechnology, and healthcare manufacturers in creating compliant and efficient manufacturing operations that are ready for inspection.
Our GMP Services in Singapore Include:
- GMP Audits & Quality System Reviews – Evaluation of manufacturing operations and quality management systems.
- Quality Management System (QMS) Support – Development and optimization of GMP-compliant quality frameworks.
- Deviation Management & CAPA – Strengthening investigations, root cause analysis, and corrective actions.
- Inspection Readiness Programs – Gap assessments, mock inspections, and regulatory preparation.
- Process Validation & GMP Consulting – Support for validation activities and quality risk management.
- Documentation & Compliance Management – Review of SOPs, batch records, and quality documentation.
- Regulatory Alignment – Compliance with HSA requirements, PIC/S GMP, WHO GMP, and international quality standards.
Zenovel delivers practical GMP solutions that strengthen quality systems, improve operational efficiency, and help manufacturers maintain continuous regulatory compliance and inspection readiness.
GMP Audit Services in Singapore for Manufacturing Quality Assurance
Enhancing Manufacturing Compliance Through Independent GMP Audits
Regular GMP audits are essential for pharmaceutical manufacturers to uphold product quality, enhance quality systems, and ensure regulatory compliance. Zenovel offers GMP Audit Services in Singapore, delivering independent assessments that meet HSA requirements, PIC/S GMP, and international best practices.
Our GMP Audit Services in Singapore Include:
- Manufacturing & Facility Audits – Evaluation of production processes, equipment, utilities, and quality systems.
- GMP Gap Analysis & CAPA Review – Identification of compliance gaps and assessment of corrective actions.
- Quality System & Documentation Audits – Review of SOPs, deviation management, change controls, and quality documentation.
- Inspection Readiness Support – Mock audits, compliance assessments, and regulatory inspection preparation.
Zenovel provides organizations with practical, risk-based audit solutions to enhance GMP compliance, boost operational performance, and ensure readiness for inspections, promoting long-term manufacturing excellence.
Pharma Plant Setup & Upgradation Services in Singapore for GMP Compliance
Transforming Future-Ready Pharmaceutical Manufacturing Facilities Through GMP Excellence
Singapore is a leading pharmaceutical manufacturing hub with advanced infrastructure and a skilled workforce. Setting up or upgrading manufacturing facilities mandates careful engineering, quality systems, and regulatory compliance. Zenovel offers services for Pharma Plant Setup and Upgradation, ensuring compliance with HSA, PIC/S GMP standards, EU-GMP guidelines, and global quality frameworks.
New Pharma Plant Setup Services in Singapore
- Facility Planning and Engineering Design: GMP-compliant facility layouts, material and personnel flow designs, warehousing strategies, and manufacturing area planning.
- Cleanroom Design and Qualification: Support for cleanroom classification, qualification, environmental monitoring, and contamination control programs.
- HVAC and Utility Qualification: Qualification of critical utilities, including HVAC systems, purified water systems, compressed air, clean steam, and supporting infrastructure.
- Equipment Qualification and Validation: IQ, OQ, and PQ support for manufacturing, packaging, laboratory, and utility equipment to ensure operational reliability and compliance.
- Quality Management System Implementation: Development of SOPs, quality policies, deviation management processes, CAPA programs, change control systems, and compliance frameworks.
- Process Validation Support: Planning, execution, and documentation of process validation activities to ensure consistent manufacturing performance and product quality.
Existing Plant Upgradation Services in Singapore
- GMP Gap Assessments and Remediation Programs
- Facility Modernization and Infrastructure Improvements
- Contamination Control Strategy Enhancement
- Manufacturing Process Optimization
- Capacity Expansion and Technology Integration
- Quality System Strengthening and Compliance Monitoring
- Validation and Qualification Program Enhancement
- Inspection Readiness and Regulatory Compliance Support
Zenovel provides services that ensure compliance with HSA regulations, PIC/S GMP requirements, EU-GMP standards, and WHO GMP principles. Our offerings include the development of Validation Master Plans, qualification documentation, validation protocols, compliance reviews, and inspection readiness programs. By integrating expertise in engineering, validation, quality assurance, and regulatory compliance, Zenovel aids organizations in achieving high-performing pharmaceutical manufacturing facilities that enhance operational excellence and product quality.
Pre-Inspection Readiness Services in Singapore for GMP Compliance
Building Inspection Confidence Through Proactive GMP Readiness
Regulatory inspections are crucial for GMP compliance, product quality, and regulatory confidence. Zenovel offers Pre-Inspection Readiness Services in Singapore to assist pharmaceutical, biotechnology, and healthcare manufacturers in assessing compliance, enhancing quality systems, and preparing for inspections, in line with HSA requirements, PIC/S GMP, EU-GMP, WHO GMP, and other international standards.
Our Pre-Inspection Readiness Services in Singapore Include:
- GMP Compliance Assessments: Reviews of manufacturing operations, facilities, quality systems, and GMP processes to identify compliance gaps and improvement opportunities.
- Mock Regulatory Inspections: Simulation of regulatory inspections to assess organizational preparedness, identify potential findings, and strengthen inspection readiness.
- Data Integrity and CAPA Evaluations: Assessment of data governance practices, audit trails, deviation investigations, computerized systems, and CAPA effectiveness to ensure regulatory compliance.
- Quality Documentation Reviews: Evaluation of SOPs, batch manufacturing records, validation documentation, training records, change control systems, and quality documentation.
- Inspection Strategy and Response Planning: Development of inspection management plans, regulatory communication strategies, and structured response frameworks for successful inspections.
- Personnel Training and Inspection Coaching: Practical training for manufacturing and quality teams on inspector interactions, documentation management, interview techniques, and inspection responsibilities.
- Validation and Qualification Reviews: Assessment of equipment qualification, process validation, cleaning validation, utility qualification, and computerized system validation programs.
Zenovel aids manufacturers in enhancing GMP compliance and inspection preparedness and minimizing regulatory risks through practical, risk-based solutions. Our experts assist organizations in developing robust quality systems, ensuring operational excellence, and sustaining compliance with both Singaporean and international regulations.
Clinical & Scientific Expert Services in Singapore for Drug Development Excellence
Accelerating Drug Development Through Scientific Expertise and Strategic Clinical Guidance
Singapore is a premier life sciences and biomedical innovation hub in Asia, characterized by a robust research ecosystem, advanced healthcare infrastructure, and a respected regulatory framework. Zenovel offers Clinical & Scientific Expert Services to support pharmaceutical and healthcare organizations throughout the product development lifecycle, enhancing strategies, optimizing study design, and producing high-quality scientific evidence for regulatory and commercial success.
Our Clinical & Scientific Expert Services in Singapore Include:
- Clinical Development Strategy and Protocol Design: Development of clinical development plans, target product profiles, study protocols, and other relevant materials.
- Translational Research and PK/PD Support: Scientific guidance on translational medicine, dose optimization, pharmacokinetic/pharmacodynamic (PK/PD) analysis, and exposure-response evaluation.
- Biomarker and Endpoint Strategy: Identification of clinically relevant biomarkers, study endpoints, and outcome measures to strengthen study design and evidence generation.
- Clinical Study Design Optimization: Evaluation of study methodology, patient populations, eligibility criteria, statistical considerations, and operational feasibility to improve trial efficiency.
- Therapeutic and Medical Consulting: Expert advice on disease areas, clinical development strategies, unmet medical needs, and benefit-risk assessment throughout product development.
- Regulatory Scientific Consulting: Strategic scientific support for regulatory interactions, development planning, and alignment with HSA and international regulatory expectations.
- Clinical Evidence Generation: Support for literature reviews, real-world evidence strategies, scientific data interpretation, and medical communications to strengthen development programs.
- Benefit-Risk Evaluation and Decision Support: Independent scientific assessments to support key development decisions, regulatory submissions, and lifecycle management activities.
Zenovel leverages scientific, clinical, and regulatory expertise to help organizations in expediting development programs, minimizing risks, and optimizing clinical strategies. Our customized solutions facilitate evidence-based decision-making and successful product development, ensuring adherence to Singaporean and international regulatory standards.
Medical & Scientific Writing Services in Singapore for Regulatory and Clinical Documentation
Delivering Accurate Scientific Documentation for Regulatory and Clinical Success
High-quality medical documentation is crucial for clinical development and regulatory submissions. Zenovel offers Medical & Scientific Writing Services in Singapore, aiding pharmaceutical and biotech companies, medical device manufacturers, CROs, and healthcare organizations with scientifically accurate and regulatory-compliant documents. Our seasoned medical writers ensure clarity and consistency, adhering to the HSA requirements and international regulatory standards.
Our Medical & Scientific Writing Services in Singapore Include:
- Clinical Study Reports (CSRs), Clinical Trial Protocols, and Investigator Brochures (IBs)
- Informed Consent Forms and Patient-Facing Documents
- CTD and eCTD Regulatory Documentation
- Pharmacovigilance and Drug Safety Documentation
- Clinical Summaries and Regulatory Documents
- Scientific Publications and Medical Communications
- Literature Reviews and Evidence Synthesis
- Medical Device and Combination Product Documentation
Zenovel provides organizations with scientifically accurate, structured, and compliant documentation throughout the product lifecycle. Our medical writing expertise enhances document quality, streamlines regulatory submissions, supports scientific communication, and aids successful engagement with regulatory authorities in Singapore and globally.
Preclinical Support Services in Singapore for Early Drug Development
Advancing Early-Stage Drug Development Through Scientific and Preclinical Expertise
A strong preclinical development program is essential for assessing the safety and efficacy of new therapies before clinical trials. Zenovel offers Preclinical Support Services in Singapore, aiding pharmaceutical and biotechnology companies by enhancing early-stage drug development, optimizing strategies, and ensuring a smooth transition to clinical phases.
Our Preclinical Support Services in Singapore Include:
- In Vitro and In Vivo Study Support: Toxicology, safety pharmacology, efficacy, pharmacokinetic (PK), pharmacodynamic (PD), and exploratory nonclinical studies guidance.
- Bioanalytical and Translational Research Support: Integration of laboratory findings, biomarker strategies, and translational science to strengthen development programs.
- Lead Candidate Evaluation and Optimization: Assessment of pharmacological properties, safety profiles, efficacy data, and candidate selection to support development decisions.
- ADME and Drug Metabolism Support: Guidance on absorption, distribution, metabolism, and excretion (ADME) studies to improve understanding of drug behavior and optimize development strategies.
- Preclinical Development Strategy Consulting: Planning of nonclinical development programs, study sequencing, and regulatory pathways to support clinical trial readiness.
- Toxicology and Safety Assessment Support: Scientific support for general toxicology, genotoxicity, reproductive toxicology, carcinogenicity, and safety pharmacology programs.
- Biomarker and Translational Science Strategy: Development of biomarker strategies and translational research plans to strengthen evidence generation and clinical decision-making.
- Regulatory Documentation Support: Preparation and review of nonclinical summaries, Investigator’s Brochures, briefing packages, and supporting documentation for regulatory submissions.
Zenovel integrates scientific expertise and regulatory knowledge to assist organizations in producing reliable preclinical data, enhancing development strategies, and reducing early-stage development risks. We offer customized solutions that facilitate the transition from discovery research to clinical development, ensuring compliance with HSA expectations and global regulatory standards.
Regulatory Affairs & Compliance Services in Singapore for Global Market Access
Sourcing Strategic Regulatory Expertise through Faster Product Approval
Singapore is a prominent hub for life sciences and pharmaceuticals in Asia, supported by a strong regulatory framework and an innovation ecosystem. Zenovel offers Regulatory affairs & Compliance Services to assist pharmaceutical, biotechnology, medical device, and healthcare organizations in meeting the HSA requirements and aligning with international standards such as ICH, FDA, EMA, and WHO throughout the product lifecycle.
Our Regulatory Affairs Services in Singapore Include:
- Regulatory Strategy Development & Gap Analysis: Development of customized regulatory strategies, compliance assessments, risk evaluations, and submission roadmaps.
- CTD/eCTD Dossier Preparation & Management: Comprehensive support for Clinical Trial Applications (CTAs), New Drug Applications (NDAs), Marketing Authorization submissions, and CTD/eCTD dossier preparation.
- Submission Planning & Regulatory Coordination: Management of submission timelines, document consistency, regulatory tracking, and cross-functional coordination.
- Labeling Compliance & Regulatory Intelligence: Preparation and review of product labeling, packaging information, and regulatory documentation in line with evolving regulatory requirements.
- Lifecycle Management & Post-Approval Support: Assistance for variations, renewals, change management, product lifecycle maintenance, and post-approval regulatory activities.
- Health Authority Interaction Support: Preparation for regulatory meetings, scientific advice, responses to regulatory queries, and communication with health authorities.
- Global Regulatory Consulting: Strategic guidance for multinational product registrations, regulatory harmonization, and global market expansion.
- Regulatory Compliance & Risk Management: Identification of regulatory risks, compliance monitoring, and implementation of proactive strategies to support sustainable regulatory compliance.
Zenovel offers regulatory expertise, scientific knowledge, and industry experience to assist organizations in navigating regulatory pathways. Our services enhance submission efficiency, strengthen compliance, reduce regulatory risks, and aid in product approvals in Singapore and other international markets.
Dossier Due Diligence Services in Singapore for Regulatory Submission Excellence
Strengthening Regulatory Confidence Through Comprehensive Dossier Review
A well-prepared regulatory dossier is crucial for product approvals and reducing review delays. Zenovel offers Dossier Due Diligence Services in Singapore to assist pharmaceutical, biotechnology, medical device, and healthcare organizations in assessing the completeness and compliance of their submission dossiers. Our experts perform thorough reviews of CTD/eCTD submissions to ensure they meet HSA requirements, ICH guidelines, and international regulatory standards.
Our Dossier Due Diligence Services in Singapore Include:
- CTD/eCTD Gap Analysis: Identification of missing information, inconsistencies, formatting deficiencies, and documentation gaps across all submission modules.
- Clinical, Nonclinical, and CMC Review: Comprehensive assessment of scientific data, technical documentation, and consistency across clinical, nonclinical, and quality sections.
- Regulatory Compliance Assessment: Evaluation of dossier content against HSA requirements, ICH guidelines, and applicable international regulatory expectations.
- Cross-Module Consistency Review: Verification of alignment between modules to ensure a coherent scientific narrative and supporting evidence throughout the submission.
- Submission Risk Assessment: Identification of potential regulatory concerns, scientific deficiencies, and issues that may impact the review or approval process.
- Data Integrity and Traceability Review: Assessment of document traceability, source data consistency, supporting references, and overall dossier integrity.
- Quality and Editorial Review: Enhancement of document structure, scientific clarity, technical accuracy, and overall submission quality.
- Regulatory Readiness Evaluation: Final review of dossier completeness with practical recommendations
Zenovel enhances the quality and regulatory preparedness of submission dossiers via structured scientific and compliance reviews. This due diligence minimizes regulatory risks, improves submission quality, and facilitates efficient interactions with health authorities, ensuring timely product approvals and market access.
eCTD Compilation Services in Singapore for Global Regulatory Submissions
Delivering Accurate, Compliant, and Submission-Ready eCTD Dossiers
Electronic Common Technical Document (eCTD) submissions are vital for regulatory filings, and Zenovel offers eCTD Compilation Services in Singapore to assist various organizations in preparing compliant and high-quality submissions. We ensure adherence to HSA requirements and ICH eCTD specifications, facilitating smooth regulatory review and global market access.
Our eCTD Compilation Services in Singapore Include:
- Document Formatting and Module Organization: Preparation and organization of regulatory documents in CTD/eCTD format with consistent structure across all submission modules.
- Hyperlinking, Bookmarking, and eCTD Publishing: Creation of fully navigable eCTD submissions with compliant hyperlinks, bookmarks, and publishing standards.
- CTD to eCTD Conversion: Conversion of existing CTD dossiers into fully compliant eCTD submissions while preserving document integrity and consistency.
- Technical Validation and Compliance Review: Verification of dossier structure, formatting, hyperlinks, validation reports, and technical compliance before submission.
- Lifecycle Management and Sequence Planning: Management of submission sequences for variations, renewals, responses to regulatory queries, and other post-approval activities.
- Submission Quality Control: Comprehensive quality review to ensure dossier completeness, technical accuracy, consistency, and submission readiness.
- Regulatory Publishing Support: Publishing support for clinical trial applications, marketing authorization applications, lifecycle maintenance, and regulatory updates.
- Global Submission Strategy Support: Preparation of dossiers aligned with regional and international regulatory requirements to facilitate efficient global submissions.
Zenovel leverages regulatory expertise and advanced publishing to produce high-quality eCTD submissions that align with global standards. This structured approach improves accuracy, reduces technical flaws, accelerates regulatory review, and aids organizations in obtaining faster approvals in Singapore and globally.
Environmental Risk Assessment (ERA) Services in Singapore for Pharmaceutical Compliance and Sustainability
Supporting Sustainable Development Through Environmental Risk Assessment
Environmental sustainability is crucial in pharmaceutical development and regulatory compliance. Environmental Risk Assessments (ERAs) enable organizations to assess the environmental impact of their products. Zenovel offers ERA services in Singapore, assisting the pharmaceutical, biotechnology, and healthcare sectors in managing environmental risks and enhancing regulatory compliance through expert-driven, practical ERA solutions.
Our environmental risk assessment services in Singapore include the following:
- Phase I and Phase II Environmental Risk Assessments
Preparation and execution of environmental risk assessments for medicinal products in accordance with internationally recognized regulatory requirements. - PEC and PNEC Calculations
Estimation of Predicted Environmental Concentrations (PEC) and Predicted No-Effect Concentrations (PNEC) to support environmental risk characterization. - Ecotoxicological Data Assessment
Scientific evaluation and interpretation of ecotoxicity data to assess potential impacts on aquatic and terrestrial ecosystems. - Environmental Exposure and Risk Characterization
Assessment of environmental hazards, exposure pathways, risk characterization, and mitigation measures to support regulatory decision-making. - Manufacturing and Waste Management Assessments
Evaluation of waste management practices, wastewater control, emissions, and environmental sustainability initiatives across manufacturing operations. - ERA Documentation and Regulatory Support
Preparation and review of ERA reports and supporting documentation for regulatory submissions. - Environmental Risk Mitigation Strategies
Development of practical risk management approaches to minimize environmental impact and strengthen long-term regulatory compliance.
Zenovel’s ERA services comply with HSA and international regulatory standards, including EMA and ICH. We facilitate the integration of environmental responsibility in pharmaceutical product development through rigorous assessments and regulatory support, ensuring compliance and promoting sustainable innovation throughout the product lifecycle.
EU QP Support Services in Singapore for Batch Release and GMP Compliance
Supporting GMP-Compliant Batch Release for Global Market Access
Efficient batch release and stringent quality oversight are crucial for product quality and regulatory compliance. Zenovel offers EU QP Support Services in Singapore aimed at improving batch release processes for pharmaceutical manufacturers, biotechnological firms, CMOs, and exporters, ensuring adherence to European GMP standards and maintaining high-quality benchmarks in line with international pharmaceutical quality frameworks.
Our EU QP Support Services in Singapore Include the Following:
- Batch Record Review and GMP Compliance Verification: Comprehensive assessment of manufacturing, packaging, testing, and quality documentation to support compliant batch release decisions.
- Deviation and Quality Impact Assessment: Evaluation of deviations, investigations, out-of-specification (OOS) results, change controls, and CAPA activities to determine their impact on product quality.
- QP Coordination and Batch Release Support: Facilitation of documentation reviews, quality assessments, and coordination activities required for Qualified Person (QP) certification.
- Quality Documentation Review: Assessment of Certificates of Analysis (CoA), validation reports, stability data, environmental monitoring records, and supplier qualification documentation.
- Regulatory Compliance Verification: Review of compliance with EU GMP Guidelines, Annex 16 requirements, PIC/S GMP standards, and other applicable international regulations.
- Supply Chain and Manufacturing Quality Oversight: Evaluation of manufacturing controls, supplier quality systems, traceability processes, and product quality throughout the supply chain.
- Inspection Readiness and GMP Compliance Support: Preparation through GMP assessments, documentation reviews, mock audits, and quality system evaluations.
- Lifecycle Quality and Compliance Support: Ongoing support for quality risk management, post-approval compliance activities, continuous improvement, and GMP system enhancement.
Zenovel aids organizations in creating efficient and compliant batch release processes, reducing regulatory risks, and facilitating access to European and global markets. Our team leverages GMP, quality assurance, and regulatory expertise to enhance compliance, boost operational efficiency, and ensure products meet international quality standards.
Regulatory Gap Analysis Services in Singapore for Compliance Readiness
Identifying Compliance Gaps to Strengthen Regulatory Success
Maintaining regulatory compliance necessitates ongoing evaluation of quality systems and operational processes. Zenovel offers Regulatory Gap Analysis Services in Singapore, assisting pharmaceutical, biotechnology, medical device, and healthcare organizations in identifying compliance gaps, mitigating regulatory risks, and enhancing inspection readiness, in line with HSA requirements, ICH guidelines, PIC/S GMP, and global regulatory standards.
Our Regulatory Gap Analysis Services in Singapore Include:
- Dossier & Documentation Review – Assessment of clinical, nonclinical, and quality documentation for completeness, consistency, and compliance.
- Quality System Evaluation – Review of SOPs, QMS, CAPA, change control, deviation management, and governance processes.
- Regulatory Submission Readiness – Evaluation of submission packages before regulatory filing.
- Clinical & GMP Compliance Assessments – Review of GCP, GMP, quality systems, validation, and operational compliance.
- Risk Assessment & Remediation Planning – Identification of compliance gaps with practical corrective action recommendations.
- Regulatory Benchmarking – Comparison of current practices against HSA requirements and international regulatory expectations.
Zenovel aids organizations in enhancing compliance frameworks, boosting operational efficiency, and confidently preparing for regulatory inspections via practical, risk-based gap assessments.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
